- Report
- February 2024
- 70 Pages
Africa, Middle East
From €4501EUR$4,750USD£3,799GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4501EUR$4,750USD£3,799GBP
- Report
- February 2024
- 70 Pages
North America
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 80 Pages
Europe
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 80 Pages
Africa
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 70 Pages
Spain
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 70 Pages
Africa, Middle East
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 80 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 110 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 70 Pages
North America
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 70 Pages
Asia Pacific
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 70 Pages
South Korea
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4501EUR$4,750USD£3,799GBP
- Report
- May 2023
- 160 Pages
Global
From €4690EUR$4,949USD£3,958GBP
- Report
- May 2023
- 147 Pages
Global
From €4690EUR$4,949USD£3,958GBP
- Report
- March 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,319GBP
- Report
- March 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,319GBP
- Report
- August 2023
- 145 Pages
Global
From €2985EUR$3,150USD£2,519GBP
- Report
- January 2022
- 60 Pages
Global
From €3743EUR$3,950USD£3,159GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more